Member-only story
The FDA understands that there is increasing interest
In October 2019, Former FDA (The Food and Drug Administration) Commissioner Scott Gottlieb, MD, publicly shared his opinion by saying, “We should make it easier to get medical Cannabis and treat it the same way we treat drugs.” FDA has already approved one drug that contains compounds derived from Cannabis. “These drugs have important therapeutic value, and we must continue to do what we can to support the science needed to develop new drugs from Cannabis,” emphasized Dr.Sharpless at the FDA public hearing earlier this year. There is a lack of research and clinical evidence to support numerous claims regarding CBD oil and CBD -oil-related products. Not because the CBD or THC efficiency is lacking, au contaire, we have many unanswered questions because hemp, Cannabis, and marijuana were on controlled substances list for very long. Regulatory barriers were hampering the research. Finally, hemp had been removed from the controlled substance list on December 20, 2018.
